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Abstract
An understanding of why certain Acinetobacter species are more successful in causing nosocomial infections, transmission
and epidemic spread in healthcare institutions compared with other species is lacking. We used genomic, phenotypic and
virulence studies to identify differences between Acinetobacter species. Fourteen strains representing nine species were
examined. Genomic analysis of six strains showed that the A. baumannii core genome contains many genes important for
diverse metabolism and survival in the host. Most of the A. baumannii core genes were also present in one or more of the
less clinically successful species. In contrast, when the accessory genome of an individual A. baumannii strain was compared
to a strain of a less successful species (A. calcoaceticus RUH2202), many operons with putative virulence function were found
to be present only in the A. baumannii strain, including the csu operon, the acinetobactin chromosomal cluster, and
bacterial defence mechanisms. Phenotype microarray analysis showed that compared to A. calcoaceticus (RUH2202), A.
baumannii ATCC 19606T was able to utilise nitrogen sources more effectively and was more tolerant to pH, osmotic and
antimicrobial stress. Virulence differences were also observed, with A. baumannii ATCC 19606T, A. pittii SH024, and A.
nosocomialis RUH2624 persisting and forming larger biofilms on human skin than A. calcoaceticus. A. baumannii ATCC
19606T and A. pittii SH024 were also able to survive in a murine thigh infection model, whereas the other two species were
eradicated. The current study provides important insights into the elucidation of differences in clinical relevance among
Acinetobacter species.
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Introduction
In contemporary medicine, certain Acinetobacter species have
proven to be highly successful in their ability to cause outbreaks
and develop antibiotic resistance [1,2]. However, great diversity
exists in the clinical importance of the various species, with some
being dominant as human pathogens and others merely acting as
colonizing or environmental organisms [2]. To date, with the
recent description of the novel species Acinetobacter pittii (former
name Acinetobacter genomic species [gen. sp.] 3) and Acinetobacter
nosocomialis (former name Acinetobacter gen. sp. 13TU) [3], the genus
Acinetobacter comprises 27 validly named species and 9 DNA–DNA
hybridization groups (gen. sp.) with provisional designations. A.
baumannii has long been considered the most clinically important
species, with the greatest number of healthcare–related outbreaks
and reports of multidrug resistance. More recently, and likely as a
consequence of improved laboratory identification, A. pittii and A.
nosocomialis have also surfaced as clinically significant, with
increasing reports of outbreaks and antibiotic resistance
[4,5,6,7,8,9]. Species that have less commonly been associated
with human disease include A. lwoffii, A. junii, and A. haemolyticus,
and some species have only been identified as colonizing human
skin or very rarely described as causing human disease, such as A.
johnsonii and A. radioresistens [2,6]. To our knowledge, A. calcoaceticus
has never been implicated in serious human disease [2]. However,
given the difficulty in phenotypically differentiating it from A.
baumannii, A. pittii and A. nosocomialis, these species are often
grouped together in diagnostic microbiology laboratories as the ‘A.
calcoaceticus – A. baumannii complex’.
Thus far, the attributes that make one Acinetobacter species more
adept at causing human outbreaks and disease than another are
poorly understood. Previous studies have shown that A. baumannii
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has the ability to survive in both wet and dry conditions in the
hospital environment [10,11,12]. A recent clinical study showed
that relative to A. nosocomialis, A. baumannii was an independent
predictor of mortality [4]. A variety of virulence mechanisms have
been identified in A. baumannii, including siderophore–mediated
iron acquisition systems, biofilm formation, adherence and outer
membrane protein function, the lipopolysaccharide (LPS), capsule
formation, and quorum–sensing [13,14,15,16,17,18,19,20]. Sig-
nificantly less is known about the non–baumannii species. In this
study, we used genomics, phenotype microarray analyses and
virulence studies, to identify species characteristics that may
explain why some Acinetobacter species are successful as human
pathogens and others are not.
Results
Genome Characteristics of the Acinetobacter Species
As shown in Table 1, 14 genomes were included in this analysis,
covering nine different Acinetobacter species (species names will be
used for non–baumannii species throughout). Eight strains were
sequenced as part of this study with mean coverage of 22–fold.
Overall, the species that make up the A. calcoaceticus – A. baumannii
complex had the largest genomes, with A. radioresistens having the
smallest (3.16 Mb). Genome sizes of strains within the A. baumannii
species varied by up to 289 Kb. The number of genes
corresponded to genome size, ranging from 3,690 in A. baumannii
to 2,874 in A. radioresistens (Table 1). Phylogenetic analysis showed
that the species that make up the A. calcoaceticus – A. baumannii
complex were most closely related (Figure S1). The other species
formed distinct phylogenetic branches.
Analysis of the A. baumannii Core Genome
To understand the genetic core of A. baumannii, we first analysed
the orthologous genes found in all six A. baumannii genomes. This
analysis yielded 2,800 genes, indicating that the accessory genome,
defined as the genes not found within the core A. baumannii
genome, varied between 658–1,053 genes depending on the strain.
A distribution of the A. baumannii core genome based on functional
gene categories is shown in Figure 1. Apart from genes of general
or unknown function, genes related to molecule transport and
metabolism were most abundant (35%), including amino acid
(11%), carbohydrate (5%), lipid (5%), nucleotide (3%), coenzyme
(4%) and inorganic ion (7%) processing. Interestingly, despite
Acinetobacter deriving its name from akineto meaning non–motile,
A. baumannii has several core cell motility genes. These include a
type IV pilus apparatus and pilus assembly genes (pilB, pilW, pilL,
pilJ, pilI, pilY1, pilQ, pilO, pilN, pilM), fimbrial biogenesis genes
(fimT, pilZ), and twitching motility genes (pilU, pilT, which are
important for pilus retraction). In fact, it has recently been shown
that A. baumannii is motile under certain conditions [21,22], and
this may play an important role in its ability to colonize and spread
on surfaces, and to form biofilms [23].
Comparison of A. baumannii Genome with Other
Acinetobacter Species
To begin to decipher the genetic attributes that may help
explain why some Acinetobacter species are clinically more
significant than others, we sought to identify genes only present
in pathogenic species of Acinetobacter (the six A. baumannii genomes,
and the A. pittii and A. nosocomialis genome) and not present in the
other species. This analysis identified 51 genes, including 12
putative operons, shared among these eight genomes that were not
present in the other species (Table S1). Importantly, one of these
operons was the csu operon, which includes six genes, and codes
for proteins involved in a chaperone – usher pili assembly system
[17]. This operon appears important for pili assembly, adherence
to abiotic surfaces and biofilm formation [17]. The finding that
this operon is only present in pathogenic species of Acinetobacter
further highlights its potential role in determining the clinical
success of these species. The predominant functional categoriza-
tion of the remaining genes was in molecule transport and
metabolism, and transcription (Table S1).
Comparison of Specific Strains of the A. calcoaceticus – A.
baumannii Complex
The data presented thus far provide some evidence that a small
number of core genes may partly explain the clinical success of
certain Acinetobacter species; however the number of genes that
differed between pathogenic and less pathogenic species was few,
suggesting that additional genetic characteristics that distinguish
these strains may be found among the accessory genomes. To
interrogate the accessory genome in more detail, we analysed
representative strains from the four species that make up the A.
calcoaceticus – A. baumannii complex (Table 1). A distribution of
genes is shown in Figure 2A. A total of 2747 genes were common
to all four species, with the greatest number of species-specific
genes observed in A. baumannii ATCC 19606T (Figure 2A). Based
on clusters of orthologous group (COG) functional classification,
the distribution of genes unique to A. baumannii ATCC 19606T
compared to each one of the other three strains (individual
pairwise comparisons) was similar, with the greatest number of
ATCC 19606T-specific genes having a presumptive role in amino
acid, carbohydrate and lipid transport and metabolism, and
transcription (Figure 2B).
Of most interest was the comparison between A. baumannii
ATCC 19606T and A. calcoaceticus. This comparison identified 759
genes present in A. baumannii ATCC 19606T and not in A.
calcoaceticus (Table S2). Of these, only 169 were found in the other
five A. baumannii genomes analysed in this study, indicating that the
majority (78%) were part of the accessory genome of A. baumannii
ATCC 19606T. Of the 759 genes, 333 had a COG classification,
and they were significantly overrepresented in several functions
necessary for basic bacterial growth and survival, including
transcription (56 genes), DNA replication, recombination, and
repair (33 genes), amino acid, inorganic ion and carbohydrate
transport and metabolism (66 genes), and cell envelope biogenesis
and outer membrane function (19 genes). Among the 333 genes
with a COG classification, there were 69 putative operons (Table
S2) that were enriched in virulence–related genes, including those
involved in siderophore transport and biosynthesis, LPS biosyn-
thesis, pili and biofilm formation, Curli fimbriae assembly, and
bacterial phage resistance mechanisms (Table 2). Several operons
responsible for iron handling were identified, including the
acinetobactin chromosomal locus (operons 36–39, Table 2),
encoding a key Acinetobacter siderophore [24,25]. The genetic
organisation of this locus and homologues in A. pittii, A. nosocomialis
and A. calcoaceticus are shown in Figure 3A. A. calcoaceticus and A.
nosocomialis lacked the full complement of genes that make this
locus (Table 2 and Figure 3A). We also identified a more recently
described siderophore operon (operon 17, Table 2 and Figure 3B)
[21], made up of eight genes, with A. baumannii ATCC 19606T
being the only strain with the full complement of genes, and A.
nosocomialis and A. calcoaceticus being deficient in most of them.
Several genes related to bacterial defence mechanisms were also
observed only in A. baumannii ATCC 19606T and not in A.
calcoaceticus, including those coding for ABC transporters, and
CRISPR – (Cas) and phage–resistance proteins (Table S2).
Clustered regularly interspaced short palindromic repeats
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(CRISPRs) are recently described adaptive bacterial immune
mechanisms that protect bacteria from invading foreign genetic
elements such as bacteriophages [26,27]. Such systems, when
combined with other phage resistance mechanisms, may provide a
survival benefit to the bacterial host [26]. The A. baumannii ATCC
19606T CRISPR system includes cas1 and cas3; however we could
not locate cas2, which is thought to be required with cas1 to form a
functional CRISPR system [27]. The CRISPR operon was not
found in the A. calcoaceticus, A. nosocomialis or A. pittii strains.
Comparison of the Metabolic Versatility of Specific
Strains of the A. calcoaceticus – A. baumannii Complex
Given the predominance of metabolism genes differentiating
pathogenic and less pathogenic strains (Table S1 and S2), we
analyzed the metabolic profile of the four species of the A.
calcoaceticus – A. baumannii complex using phenotype microarrays.
Of the 1920 conditions tested, the four species shared 1356
metabolic responses (70.6%), of which 795 compounds or
conditions could be utilized by all the species and 561 by none
of them. A summary of the entire metabolic profile of the four
species is shown in Figure 4A. A. baumannii ATCC 19606T
appeared to utilize peptide nitrogen sources (PM 6–8) more
effectively and to be more tolerant to pH stress (PM 10) than the
other three species. A. baumannii ATCC 19606T and A. pittii had a
reduced ability to utilise most of the phosphorus and sulfur sources
(PM 4) (Figure 4A).
We then focused on the most clinically disparate of the species,
and compared A. baumannii ATCC 19606T with A. calcoaceticus in
more detail. In 195 conditions (Table S3), A. baumannii ATCC
19606T was significantly more metabolically active than A.
calcoaceticus. These conditions comprised 10 carbon sources, 105
nitrogen sources (of which 98 were di– and tri–peptides) and 80
stress conditions, of which 26 related to osmotic and pH stress and
54 related to the presence of antimicrobials and other cytotoxic
compounds (Table S3). Apart from the likely survival advantage
inferred by the greater ability of A. baumannii ATCC 19606T to
metabolise in the presence of osmotic, pH and antimicrobial
exposure, one of the carbon sources utilized by this strain was D–
glucarate. D–glucarate is found in the human body and has been
shown to be a carbon source utilized by a range of gram–negative
bacteria [28,29]. D–glucarate catabolism generates a–ketogluta-
rate, which enhances the citric acid cycle (Figure 4B). Recently,
over–expression of the citric acid cycle was shown to occur in an A.
baumannii strain with increased virulence in the presence of ethanol
[30].
Virulence Differences between Strains of the A.
calcoaceticus – A. baumannii Complex
Given the differences in the number of putative operons with
virulence function that were observed between the four species of
the A. calcoaceticus – A. baumannii complex, we performed a range of
in vitro and in vivo virulence studies to characterise further the
functional significance of their genetic differences. Given the
predilection of A. baumannii to colonise or infect the respiratory
tract, we first analysed the interaction of the four species with
human bronchial epithelial cells. All strains could adhere to
human bronchial epithelial cells and induce a pro-inflammatory
cytokine response (IL-6 and IL-8). Adherence and IL-8 induction
were most pronounced with A. pittii (Figure 5, A, B and C). Of
note, cell monolayers remained intact and the morphology of the
cells was not affected by any of the strains (data not shown).
Given the likely importance of biofilm formation to the success
of Acinetobacter in hospitals, we next tested the four species in a
unique biofilm assay. Thus far, the correlation between biofilm
formation on abiotic surfaces and clinical significance has been
poor [31]. Therefore, we used a novel assay that may predict the
ability of Acinetobacter to colonise and form a biofilm on human skin
[32]. Using a three–dimensional human skin construct, we
observed that A. baumannii ATCC 19606T, A. pittii and A.
nosocomialis were able to multiply rapidly and persist on human
skin, whereas A. calcoaceticus grew to a significantly lower density
(Figure 5D). In addition, biofilms of the former three species were
visible on the stratum corneum after PAS-Alcian blue staining,
whereas no such bacterial structures were seen for A. calcoaceticus
(Figure 5, E and F).
Finally, we assessed the survival of the four strains in a
neutropenic mouse thigh muscle infection model, which is a soft-
tissue model previously used for Acinetobacter infection [33]. A.
Figure 1. A. baumannii core genome. Functional distribution of the genes found in all six A. baumannii strains included in this study.
doi:10.1371/journal.pone.0046984.g001
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calcoaceticus and A. nosocomialis were eradicated from the mouse
thigh muscles, whereas bacteria of A. baumannii ATCC 19606T and
A. pittii could be detected in the muscles after 48 hours (Figure 5G).
Discussion
This study provides a combined genomic, phenotypic and
virulence assessment of a range of Acinetobacter species that have
been variably associated with humans. From a genomic analysis of
nine different Acinetobacter species, we identified a small number of
genes unique to pathogenic species. The majority of these genes
are predicted to be important for molecule transport and
metabolism but also included the putative virulence csu operon.
Investigating the accessory genome of individual strains of the four
species of the A. calcoaceticus – A. baumannii complex, we found a
range of putative operons with predicted functions related to host
survival and virulence in A. baumannii ATCC 19606T but not in A.
calcoaceticus. A. pittii appeared most similar to A. baumannii ATCC
19606T, whereas A. nosocomialis lacked several of these important
operons, particularly the full repertoire of genes of the acineto-
bactin chromosomal locus. Phenotype microarray studies support-
ed the genomic analysis in that A. baumannii ATCC 19606T was
able to utilise more carbon and nitrogen sources, and was more
tolerant to a range of cellular stresses than A. calcoaceticus.
Moreover, the pathogenic species were able to multiply and form
biofilms on human skin significantly more than A. calcoaceticus.
Only A. baumannii and A. pittii were able to survive in a mammalian
thigh infection model.
As a consequence of improved laboratory speciation, it is
becoming apparent that non–baumannii species, particularly A.
nosocomialis and A. pittii, are clinically significant human pathogens.
For example, in a recent study from Norway, A. nosocomialis was
the most common species (47%) isolated from blood cultures over
a three–year period, followed by A. pittii (20%) [34]. With regard
to their clinical impact, a more contemporary study has shown
that relative to A. nosocomialis, bacteremia with A. baumannii was an
Figure 2. Distribution of genes in individual strains of the A. calcoaceticus – A. baumannii complex. (A) Venn diagram showing the number
of overlapping genes between the four strains that make up the A. calcoaceticus – A. baumannii complex. (B) Pairwise comparisons of the number of
genes present in A. baumannii ATCC 19606T but absent in each of A. calcoaceticus (blue), A. pittii (green) and A. nosocomialis (red).
doi:10.1371/journal.pone.0046984.g002
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independent predictor of mortality [4]. Interestingly, and consis-
tent with our study findings, there was no significant difference
between A. baumannii and A. pittii, however the number of patients
in the A. pittii group was small [4]. Genetically and metabolically,
we showed that A. pittii appeared similar to A. baumannii, and they
also behaved similarly in the mammalian infection model. Despite
its description of causing bloodstream infection, A. nosocomialis
lacked several of the putative virulence related operons, particu-
larly the acinetobactin siderophore cluster, and its phenotype was
more closely aligned to A. calcoaceticus, both of which may explain
its failure to survive in the murine model and its association with a
lower mortality in clinical studies [4].
Within mammalian hosts, free iron is often a scarce resource
and for pathogenic organisms to survive in vivo they often utilize a
range of iron scavenging systems. Such systems have been
analysed across different A. baumannii strains [21,35] however this
is the first analysis, to our knowledge, of such genes in non–
baumannii species. In addition to the acinetobactin chromosomal
locus, we observed another siderophore cluster and a putative iron
uptake receptor in A. baumannii ATCC 19606T that was not
present in A. calcoaceticus. This second cluster (operon 17 in Table 2)
is a recently described siderophore cluster made up of eight genes
that is well conserved across A. baumannii strains [21]. The full
repertoire of genes from this cluster was not found in A. pittii, A.
nosocomialis, and A. calcoaceticus, and the few homologues identified
exhibited low similarity (Table 2). Such genetic differences
between Acinetobacter species in key virulence attributes may help
explain why some species have greater clinical impact.
Apart from genes involved in metabolism and transcription, we
identified the csu operon as an operon found in pathogenic species
of Acinetobacter (six A. baumannii strains, A. pittii and A. nosocomialis)
but not in non–pathogenic species. Loss of function of this operon
leads to a lack of pili–like structures on the surface of A. baumannii
and to loss of cell attachment and biofilms on abiotic surfaces [17].
Table 2. Select operons with putative virulence function found in A. baumannii ATCC 19606T and not in A. calcoaceticus.
Operon ID Function Genes A. baumannii ATCC 19606T ORFs1 Homologues average similarity (ID% ± SD)
2
A. pittii A. nosocomialis
2 Pili assembly and biofilm
form.
csuAB/ABCDE ACIB1v1_50001–6 91.867.1 91.867.1
17 Siderophore transp. bios. cirA, menG, iucA/C, araJ, rhbE/C ACIB1v1_160094–1013 46.2617.9 31.163.7
29 Phage resistance cas1, csy1, csy2, csy3, csy4 ACIB1v1_260071–75 – –
36 Siderophore transp. bios. bauD, bauC, bauE, bauB and
bauA
ACIB1v1_480066–70 97.861.0 –
37 Siderophore transp. bios. basC and basD ACIB1v1_480071–72 97.461.0 –
38 Siderophore transp. bios. basE, basF, basG ACIB1v1_480073–75 97.660.3 47.860.4
39 Siderophore transp. bios. barA, barB, basH, basI, basJ ACIB1v1_480076–80 95.166.3 32.860.8
40 Siderophore transp. bios. tonB, PEPN ACIB1v1_490004–5 97.060.3 97.560.3
46 Cell motility and secretion pilA ACIB1v1_560044–45 60.2614.5 73.360.3
47 LPS biosynthesis lpsC and lpsE ACIB1v1_600015–164 33.85 68.2629.8
50 Curli fimbriae assembly csgG ACIB1v1_700078–80 94.861.1 –
56 LPS biosynthesis wzx, degT, wbbJ, mviM and vipA ACIB1v1_740018–226 42.6623.8 48.3617.2
Bios., Biosynthesis; Form., Formation; ID, Identity; SD, Standard Deviation; Transp., Transport.
1Based on Microbial Genome Annotation Platform (www.cns.fr/agc/mage) [55].
2Expressed as the average identity at the nucleotide level 6 standard deviation.
3Only three, two and two genes (out of eight) are found in A. pittii, A. nosocomialis and A. calcoaceticus, respectively. The homologues identified exhibited low similarity.
4Both genes belong to an LPS operon that spans from ORF ACIB1v1_600009 to 16, and which is only partially present within A. calcoaceticus (three of eight genes are
absent).
5lpsC is absent from A. pittii genome.
6Only vipA is present in A. calcoaceticus and exhibited moderate similarity. The operon is poorly conserved and partially present also in A. pittii and A. nosocomialis.
doi:10.1371/journal.pone.0046984.t002
Figure 3. Genetic organisation and conservation of the siderophore clusters found in A. baumannii ATCC 19606T and not in A.
calcoaceticus. (A) Siderophore cluster 1 (operons 36–39) is known as the acinetobactin chromosomal cluster, and (B) siderophore cluster 2 (operon
17) (See Table 2 for details about the operons). The presence of homologues for each gene in A. pittii, A. nosocomialis, and A. calcoaceticus is shown.
doi:10.1371/journal.pone.0046984.g003
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Interestingly, this operon was not shown to be important for
attachment to and cytokine production by human bronchial
epithelial cells [36]. We hypothesize that this operon may aid in
Acinetobacter attachment and colonization of plastic medical devices
such as ventilator tubing and catheters, with a subsequent
increased risk of invasive infection. The definitive role of this
operon in mammalian virulence requires further evaluation.
We observed a diverse repertoire of core metabolic genes in A.
baumannii, which is likely to be important for its ability to survive in
vivo, as well as in unique ecological niches of healthcare
institutions. To assess the global metabolic capabilities of the
Acinetobacter species, we used phenotype microarrays, which
enabled us to assess nearly 2000 metabolic and toxic compound
conditions. Overall, A. baumannii ATCC 19606T was able to utilize
nitrogen sources more effectively and was more tolerant to pH
stress than A. nosocomialis, A. pittii and A. calcoaceticus. The
differences were more marked when A. baumannii ATCC 19606T
was compared to A. calcoaceticus. Interestingly, A. baumannii and A.
pittii were unable to utilize most of the phosphorus sources despite
both strains having the necessary genetic composition for
phosphate metabolism. Several studies have highlighted the key
role of the Pho regulon not only in phosphate management, but
also in virulence and stress responses in many bacteria [37].
Whether the inability of A. baumannii and A. pittii to utilize
phosphorus is linked to expression of the Pho regulon remains a
question that needs further evaluation.
Taken together, these data are hypothesis generating and
provide important insights into understanding the potential
differences between species of the Acinetobacter genus. We describe
genetic and metabolic characteristics that support why some
species may be more clinically important than others, and also
highlight the functional significance of these differences in various
virulence models. Limitations of our study are that we only
analysed one strain for each of the non-baumannii species, and our
results need confirmation using a larger set of strains. However, to
our knowledge this is the first genetic and metabolic description of
such a diverse range of Acinetobacter species. Furthermore,
confirmation of our findings using targeted gene deletion and
complementation is required to define the significance and role of
the species-specific operons found in pathogenic versus non-
pathogenic species. Finally, our study has examined the presence
or absence of genes between strains; however polymorphic
differences in shared genes may also contribute to phenotypic
differences. A full analysis of genotype-phenotype associations will
Figure 4. Metabolic diversity of specific strains of the A. calcoaceticus – A. baumannii complex. (A) Phenotype Microarray (PM) comparative
results showing the number of compounds used (green) or not used (red) by A. baumannii ATCC 19606T [A], A. nosocomialis [B], A. pittii [C] and A.
calcoaceticus [D]. The external circle and PM number represent the Biolog plate number. (B) A. baumannii ATCC 19606T is able to metabolise the
carbon source, D–glucarate and produce a–Ketoglutarate through the functional enzymes, D–glucarate dehydrogenase and KDG dehydratase. a–
Ketoglutarate is then utilized in the citrate cycle. These enzymes are not found in A. calcoaceticus.
doi:10.1371/journal.pone.0046984.g004
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require data from many additional strains of each species. Overall,
these data provide important insights into the potential differences
in clinical relevance among Acinetobacter species.
Materials and Methods
Ethics Statement
The animal studies performed in this study were approved by
the Leiden Experimental Animal Committee (permit number
10038) and were performed in compliance with The Experiments
on Animals Act of 1996, which is the Dutch law related to the
conduct of animal experiments. All efforts were undertaken to
minimize suffering.
Bacterial Strains and Culture Conditions
The 14 strains included in this study are shown in Table 1. The
genomes of eight strains were sequenced in the present investiga-
tion, while for six strains, the publicly available genomes were used
(Table 1). Cultures were performed at 30uC or 37uC on sheep
blood agar plates (bioMe´rieux, Boxtel, The Netherlands) or in
Luria–Bertani (LB) broth.
Figure 5. Virulence attributes of individual strains belonging to the A. calcoaceticus – A. baumannii complex. (A) Adherence of A.
baumannii ATCC 19606T, A. pittii, A. nosocomialis and A. calcoaceticus to human bronchial epithelial cells after 1 hour. Results are expressed as mean
number of bacteria per 100 epithelial cells 6 standard deviation (SD) of two independent experiments performed in duplicate. The asterisk signifies
statistical significance (P,0.05) between A. pittii and A. baumannii. The comparison between A. pittii and A. calcoaceticus was also significant
(P,0.05). (B) Levels of IL–6 and (C) IL–8 in the culture medium of human bronchial epithelial cells after 24 hour stimulation with specific strains of the
A. calcoaceticus – A. baumannii complex. Results are expressed as mean levels of IL–6 and IL–8 (in ng/ml) 6 SD of three independent experiments.
Asterisk signifies statistical significance (P,0.05) between A. pittii and A. baumannii. The comparison between A. pittii and A. calcoaceticus was also
significant (P,0.05).. (D) Persistence and biofilm formation of A. baumannii ATCC 19606T (squares), A. pittii (upward triangles), A. nosocomialis
(downward triangles) and A. calcoaceticus (diamonds) on three–dimensional human skin constructs. Results are expressed as mean CFU per skin
construct 6 SD of three independent experiments. Dotted line represents the lower limit of detection. Asterisk signifies statistical significance
comparing A. calcoaceticus with A. baumannii ATCC 19606T (P,0.05) (E) Alcian–blue PAS staining shows biofilm formation (black arrow) on human
skin constructs by A. baumannii ATCC 19606T but not by (F) A. calcoaceticus. Scale bar is equivalent to 20 mm. (G) Approximately 16104 CFU were
injected in the thigh muscles of neutropenic mice and the number of viable bacteria was determined after 48 hrs. Results are expressed as mean
number of bacteria (in CFU/muscle) 6 SD from three animals. Dotted line represents lower limit of detection. Asterisk signifies statistical significance
(P,0.05) between A. baumannii and A. nosocomialis or A. calcoaceticus.
doi:10.1371/journal.pone.0046984.g005
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Whole Genome Sequencing
Genomic DNA was extracted using the Invitrogen Easy–DNA
kit (Invitrogen, CA, USA) or as described by Boom et al. [38].
Genomes were sequenced using 454 FLX pyrosequencing (Roche)
with DNA standard fragment and 3 kb jumping libraries
according to the manufacturer’s recommendations [39]. Genomes
were assembled using Newbler and annotation was performed
using a combination of ab initio and evidence–based approaches
(see Text S1).
Phylogenetic Analysis and Comparative Genomics
Predicted proteins from each Acinetobacter genome were com-
pared using an all–against–all BLAST search and Pseudomonas
aeruginosa PAO1 was used as the outgroup. Reciprocal best blast
matches (RBM), regardless of percent identity, were stored in a
custom MySQL relational database to facilitate identification of
orthologous groups shared by selected phylogenetic and pheno-
typic groups of organisms. RBM matching proteins were clustered
using the Markov clustering algorithm implemented in MCL [40],
and clusters with one protein per genome were defined. These
represent orthologous core genes that are present as a single copy
in each genome. The protein sequences for each cluster were
aligned using CLUSTALW [41] and the resulting multiple
sequence alignments were concatenated for tree building. A
neighbour joining (NJ) tree was made using MEGA4 [42] and
evaluated using 100 bootstrap replicates. The criteria used to
define a putative operon were (i) genes were consecutive, (ii) genes
were transcribed in the same orientation, (iii) the intergenic
distance between the genes was no longer than 150 bp, and (iv)
gene length was at least 450 bp [43,44].
Metabolic Profiling
To assess for metabolic differences between Acinetobacter species,
we used Phenotype Microarrays (PM) as described previously by
Biolog Inc. (Hayward, CA, USA) [45]. This technology uses
tetrazolium violet irreversible reduction to formazan as a reporter
of active metabolism. Twenty 96–well microarray plates were used
(PM 1–20) comprising 1920 different metabolic and toxic
compound conditions. The analysis of PM data was carried out
on the raw data–set provided by Biolog Inc., obtained by three
replicates of each substrate. Binary coefficients (1/0) for positive
metabolism (1) or no metabolic activity (0) were attributed to each
PM well and a matrix of binary vectors, each representing a single
Acinetobacter species, was prepared as previously described [46].
Binary data were then used to compute a similarity matrix by
using Jaccard coefficient with the software PAST [47]. See text S1
for more details.
Growth on Human Skin Equivalents
Human keratinocytes were isolated from fresh mamma
reduction surplus skin and human epidermal skin constructs were
generated as previously described [32,48]. In brief, human
epidermal skin constructs were incubated with 300 ml of a mid–
logarithmic bacterial suspension (36105 colony forming units
[CFU]/ml) at 37uC (7.3% CO2). After 1 h, skin constructs were
washed with phosphate buffered saline (PBS) to remove non–
adherent bacteria and were incubated air-exposed for an
additional 23 hr and 47 hr. Two circular biopsies (4 mm in
diameter) were taken from the skin, homogenized in PBS and
serially diluted to determine the number of CFU. A third biopsy of
each skin construct was fixed in 4% formaldehyde, dehydrated
and embedded in paraffin for subsequent staining with Alcian–
blue PAS (Merck, Darmstadt, Germany) for morphological
analysis. Three independent experiments were performed.
Bronchial Epithelial Cell Adhesion and Cytokine
Production
Adherence of bacteria to human bronchial epithelial cells (H292
cells, ATCC CRL–1848, Manassas, VA, USA) and cytokine
production by these cells was determined as described previously
[36,49]. In brief, H292 cells were incubated for 1 hr at 37uC with
16108 CFU of an overnight bacterial culture on blood agar.
Bacterial adherence to H292 cells was quantified by light
microscopy and the average number of bacteria per 100 epithelial
cells was recorded. Two independent experiments were performed
in duplicate. For cytokine production, H292 cells were washed five
times after 1 hr of bacterial infection (as described above) with
prewarmed PBS, and fresh RPMI medium was added. After 23 hr
incubation at 37uC, supernatants were collected and stored at
220uC until determination of cytokine levels. RPMI medium
alone was used as a control. Interleukin (IL)–6 and IL–8 were
determined by enzyme–linked immunosorbent assays (ELISA,
Biosource, CA, USA) according to the manufacturer’s instructions.
The lower limit of detection was 15 pg/ml for IL–6 and 7 pg/ml
for IL–8. Three independent experiments were performed.
Murine Thigh Infection Model
The survival of Acinetobacter strains in a mouse thigh muscle
infection model was assessed as previously described [33], with
modifications. Female Swiss mice (Charles River Nederland,
Maastricht, The Netherlands) were made transiently neutropenic
by intraperitoneal injection with cyclophosphamide (150 mg/kg
body weight in 150 ml) on day 4 and 3 prior to infection.
Approximately 16104 CFU (in 50 ml of saline) of a mid–
logarithmic culture was injected in the right thigh muscle (three
animals per strain). At 48 hr after infection, mice were sacrificed
and infected thigh muscles were removed and homogenized in
1 ml PBS and viable counts were performed.
Statistical Analysis
All data were analysed for statistical significance using the
Wilcoxon rank sum test. P values of #0.05 were considered
statistically significant.
Supporting Information
Figure S1 Phylogenetic analysis of the eight sequenced strains of
Acinetobacter species from this study.
(TIF)
Table S1 Unique genes found in pathogenic species of
Acinetobacter (A. baumannii [six strains], A. pittii and A. nosocomialis)
and not in other less or non-pathogenic species. Highlighted areas
represent putative operons.
(DOC)
Table S2 Unique genes found in A. baumannii ATCC 19606T
compared to A. calcoaceticus, and their functional characterisation.
Highlighted areas represent putative operons.
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Table S3 Metabolic gains found in A. baumannii ATCC 19606T
but not in A. calcoaceticus using phenotypic microarrays (PM).
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